Long-Term Open-Label Extension Study of Oral Levosimendan

Clinical trial NCT07436689 · ENROLLING_BY_INVITATION

Trial details

NCT number: NCT07436689
Sponsor: Tenax Therapeutics, Inc.
Status: ENROLLING_BY_INVITATION
Phase: Phase 3
Study type: INTERVENTIONAL

Pulmonary Hypertension Associated With HFpEF

Start date: 2026-03-13
Primary completion: 2029-03-01
Enrollment: 800

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.